New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Biodesix, Inc.
BDSX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

124M

Medical - Diagnostics & Research

Next Earning date - 14 May 2025

124M

Medical - Diagnostics & Research

Next Earning date - 14 May 2025

0.85USD

Shape0.03 ( 3.80%)
Market Closed (as of Mar 21, 20:00 EDT)
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-60%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

59%

Quote Panel

Shape
Updated March 22, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap


  • Shares Outstanding


  • Share in Float


  • Dividende


  • Earning Date

    No Data


  • Price Target


  • Average Volume


  • Beta


  • Range


  • Industry


  • Website


  • Sector


Fundamentals

Shape

Relative Strength

Shape

BDSX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$93M

Shape355%

2025-Revenue

$0.21

Shape-225%

2025-EPS

$62M

Shape-1120%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

0.00(-100.00%)

Number of analyst

0

Last analyst upgrade/downgrade

Scotiabank

initialise

Previous: Not converted

2024-09-16

Now: Outperform

Craig-Hallum

initialise

Previous: Not converted

2024-07-26

Now: Buy

Cowen & Co.

initialise

Previous: Not converted

2024-05-13

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.24
vs -0.50

Q2.23

arrow
arrow

N/A

-0.17
vs -0.40

Q3.23

arrow
arrow

N/A

-0.12
vs -0.34

Q4.23

arrow
arrow

N/A

-0.10
vs -0.28

Q1.24

arrow
arrow

N/A

-0.14
vs -0.24

Q2.24

arrow
arrow

N/A

-0.08
vs -0.17

Q3.24

arrow
arrow

N/A

-0.07
vs -0.12

Q4.24

arrow
arrow

N/A

-0.06
vs -0.10

Q1.25

arrow
arrow

N/A

-0.07
vs -0.14

Q2.25

arrow
arrow

N/A

-0.06
vs -0.08

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+38%

9.1M  vs 6.5M

Q2.23

arrow
arrow

+8%

11.9M  vs 10.9M

Q3.23

arrow
arrow

+21%

13.5M  vs 11.1M

Q4.23

arrow
arrow

+53%

14.7M  vs 9.6M

Q1.24

arrow
arrow

+64%

14.8M  vs 9.1M

Q2.24

arrow
arrow

+51%

17.9M  vs 11.9M

Q3.24

arrow
arrow

+35%

18.2M  vs 13.5M

Q4.24

arrow
arrow

+39%

20.4M  vs 14.7M

Q1.25

arrow
arrow

+32%

19.5M  vs 14.8M

Q2.25

arrow
arrow

+26%

22.6M  vs 17.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-376%

-3.76
vs -1.30

Q2.23

arrow
arrow

+191%

1.91
vs -3.76

Q3.23

arrow
arrow

+757%

7.57
vs 1.91

Q4.23

arrow
arrow

-200%

-2.00
vs 7.57

Q1.24

arrow
arrow

+247%

2.47
vs -2.00

Q2.24

arrow
arrow

-30%

-0.30
vs 2.47

Q3.24

arrow
arrow

-37%

-0.37
vs -0.30

Q4.24

arrow
arrow

-40%

-0.40
vs -0.37

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

28

28
vs 34

-18%

Q2.23

arrow
arrow

26

26
vs 28

-7%

Q3.23

arrow
arrow

37

37
vs 26

42%

Q4.23

arrow
arrow

39

39
vs 37

5%

Q1.24

arrow
arrow

43

43
vs 39

10%

Q2.24

arrow
arrow

47

47
vs 43

9%

Q3.24

arrow
arrow

54

54
vs 47

15%

Q4.24

arrow
arrow

60

60
vs 54

11%

Earnings Growth

Latest News